Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Single-center, Open Label Study for Evaluation of the Safety and Efficacy of Oshadi D and Oshadi R for Malignant Mesothelioma Treatment - A Phase IIa Study

NCT01627795 is registered in ClinicalTrials.gov with Oshadi Drug Administration as lead sponsor.

NCT NCT01627795
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01627795 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Single-center, Open Label Study for Evaluation of the Safety and Efficacy of Oshadi D and Oshadi R for Malignant Mesothelioma Treatment - A Phase IIa Study
Lead sponsor
Oshadi Drug Administration
Phase
Phase 1/2
Overall status
Suspended
Start date
December 31, 2016
Completion date
December 31, 2018
Enrollment
17 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

mesothelioma